Corporate earnings along with geopolitical concerns have swayed investor sentiment in recent trading sessions. But investors seeking consistent income against a volatile backdrop can always add attractive dividend-paying stocks to their portfolios. For discerning investors, top Wall Street analysts can help select the right stocks, backed by strong cash flows...
Year: 2026
If you missed big international stock market rally in 2025, it’s not too late to start making money overseas
After spending most of the past decade being trounced by the U.S. stock market, international equities are back and investing experts say the opportunity should last. A brutal stretch of underperformance that lasted a decade ended in late 2024 and has sustained its momentum at the outset of 2026. After...
Wealth inequality and the ‘K-shaped’ economy are more striking than ever, data shows
The gap between the best and worse off Americans is growing — and economists don't see an end in sight.The "K-shaped" economy has been top of mind for consumers, corporate leaders, policymakers and investors since the Covid pandemic drastically reshaped Americans' financial habits almost six years ago. Economists now warn...
Democratic states seek to hike taxes on the wealthy
A version of this article first appeared in CNBC's Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox.A new "blue wave" of tax hikes on the wealthy is rippling through state legislatures, as Virginia, Washington state,...
Eli Lilly CEO says Medicare coverage of obesity drugs could ‘change the game’ for upcoming pill launch
Eli Lilly CEO Dave Ricks on Friday said upcoming Medicare coverage of obesity drugs could be a major catalyst for the rollout of the company's closely watched experimental weight loss pill, orforglipron.In an exclusive interview with CNBC, Ricks said Lilly expects to have Medicare coverage for the treatment "immediately following...